Finance

Lists
RMD:ASX
Resmed CDI
A$ ३४.९६
+१.४२%
(+०.४९) 1D
नोभेम्बर १३, १६:१०:१२ GMT+११  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for RMD...
Open
A$ ३४.८५
High
A$ ३५.१४
Low
A$ ३४.८१
Mkt. cap
३३.६९ अरब
Avg. vol.
१७.५५ लाख
Volume
७.४४ लाख
52-wk high
A$ ३९.९४
52-wk low
A$ २५.५०
Shares outstanding
१४.०७ करोड
No. of employees
११ हजार
Open
A$ ३४.८५
High
A$ ३५.१४
Low
A$ ३४.८१
Mkt. cap
३३.६९ अरब
Avg. vol.
१७.५५ लाख
Volume
७.४४ लाख
52-wk high
A$ ३९.९४
52-wk low
A$ २५.५०
Shares outstanding
१४.०७ करोड
No. of employees
११ हजार
News stories
From web sources and news partners
Investing.com Nigeria
Investing.com Nigeria
·
१ दिन पहिले
Form 4 ResMed Inc: Aaron Bloomer (CFO) For: 11 November By Investing.com
Barron's
Barron's
·
१ हप्ता पहिले
Buy ResMed Stock. It’s a Bargain at This Price.
Profile
Resmed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease, and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19. Resmed also provides software to out-of-hospital care agencies to streamline transitions of care into and between these care settings for seniors and their care providers. Resmed employs more than 8,000 people worldwide as of June 2022. The company operates in more than 140 countries worldwide, and has manufacturing facilities in Australia, Singapore, France, and the United States. Revenue was US$4.7 billion in fiscal year 2024. Wikipedia
About Resmed CDI
CEOMichael J. Farrell
Employees११.४ हजार
Foundedजुन १९८९
Headquartersसान डिएगो, क्यालिफोर्निया, संयुक्त राज्य अमेरिका
SectorHealth Care
Industry-
Websiteresmed.com
Last report
२०२६ अक्टोबर २९
Fiscal period
Q1 2027
US$ ०.२९ / US$ ०.२७
+८.८१%beat
Revenue / Est. (USD)
१.४१ अरब / १.३९ अरब
+१.५५%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
२०२६ सेप्टेम्बर
Revenue
१.४२ अरब
१.४३ अरब
१.४६ अरब
१.४१ अरब
Cost of goods sold
५३.६३ करोड
५३.२६ करोड
५९.४१ करोड
५३.६४ करोड
Cost of revenue
५३.६३ करोड
५३.२६ करोड
५९.४१ करोड
५३.६४ करोड
Research and development expenses
९.१० करोड
९.४३ करोड
१०.५७ करोड
१०.१५ करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२७.५७ करोड
२७.९८ करोड
२९.३४ करोड
२८.४२ करोड
Operating expense
३८.६२ करोड
३९.३२ करोड
४१.७९ करोड
३८.५७ करोड
Total operating expenses
९२.२५ करोड
९२.५७ करोड
१.०१ अरब
९२.२२ करोड
Operating income
५०.०३ करोड
५०.५७ करोड
४५.१६ करोड
४९.२६ करोड
Other non operating income
४२.०० हजार
१.८१ लाख
४४.०२ लाख
२९.५२ लाख
EBT including unusual items
४९.६१ करोड
५०.२३ करोड
४७.४२ करोड
५३.९२ करोड
EBT excluding unusual items
५०.४५ करोड
५१.८३ करोड
४७.६१ करोड
५१.१३ करोड
Income tax expense
१०.३६ करोड
१०.३६ करोड
९.०७ करोड
१२.०७ करोड
Effective tax rate
२०.८७%
२०.६२%
१९.१४%
२२.३९%
Other operating expenses
-
-
-
-
Net income
३९.२६ करोड
३९.८७ करोड
३८.३४ करोड
४१.८४ करोड
Net profit margin
२७.५९%
२७.८६%
२६.२०%
२९.५७%
Earnings per share
२.८१
०.२९
०.३०
०.२९
Interest and investment income
४४.५९ लाख
३८.०४ लाख
३.१८ करोड
२.१२ करोड
Interest expense
-
-
-
-४८.१४ लाख
Net interest expenses
४४.५९ लाख
३८.०४ लाख
३.१८ करोड
१.६४ करोड
Depreciation and amortization charges
-
-
-
-
EBITDA
५४.३८ करोड
५५.८२ करोड
४९.०१ करोड
५३.४४ करोड
Gain or loss from assets sale
-
-
-
-६.१८ करोड
Upcoming events
AI content may include mistakes. Learn more
Google एपहरू